drugset / Trial / NCT04730050
A Phase I Clinical Trial to Investigate the Safety, Tolerability, and Pharmacokinetic Characteristics of TT-01025-CL in Healthy Subjects
RandomizedParallel-groupDouble-blindTreatment
Summary
To assess the safety, tolerability and pharmacokinetic characteristics of TT-01025 in healthy male subjects
Timeline
- Start
- 2021-02-17
- Primary completion
- 2021-12
- Completion
- 2021-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TT-01025-CL | Unknown | — | Oral |
Indications
No indication recorded.